Mesoblast (MESO) insider buying

Healthcare · Biotechnology · Market cap $1.8B

4 open-market purchases of MESO by Mesoblast's executives and directors since April 2026, worth $28M in total, from SEC Form 4 filings.

The most recent: Gregory George, Director bought $3M on April 10, 2026.

The biggest buyer over the period is Gregory George (Director): 4 purchases, $28M.

By year

YearPurchasesValue
20264$28M

Biggest buyers

InsiderBuysValue
Gregory George
Director		4$28M

Every purchase

Newest first. From SEC Form 4 filings. Insider buying across the market.

DateInsiderSharesPriceValueFiling
Apr 10, 2026 Gregory George
Director		 2,324,072$1.48$3M Form 4
Apr 9, 2026 Gregory George
Director		 1,586,890$1.44$2M Form 4
Apr 9, 2026 Gregory George
Director		 1,981,890$8.59$17M Form 4
Apr 4, 2026 Gregory George
Director		 4,000,000$1.42$6M Form 4
Every line, every quarterThe deep dive has fifteen-plus years of statements, quarterly results, charts and valuation models for MESO.
Open MESO in Investingly

Questions

Are Mesoblast insiders buying the stock?

4 open-market purchases of MESO by Mesoblast's executives and directors since April 2026, worth $28M in total, from SEC Form 4 filings. The most recent: Gregory George, Director bought $3M on April 10, 2026.

What counts as insider buying here?

Open-market purchases (Form 4 code P) by officers and directors. Option exercises, grants and purchases by 10% owners are left out.

From Mesoblast's annual reports filed with the SEC (XBRL data), standardised by Investingly. Information only, not investment advice.